Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some ...

Researchers describe a concentric supraparticle system that protects and delivers RNA therapeutics for gene silencing in ...

Moderna said revenues for the first quarter fell 35% to $108 million, hit by lower product sales as Covid becomes a more “normal” disease with demand more concentrated in the autumn winter months like ...

This valuable study provides insights into a key question in comparative neuroanatomy and development. The authors provide evidence of the role for a particular micro-RNA in regulating the development ...

Moderna faces revenue declines, regulatory setbacks, and market challenges as COVID-19 vaccine demand wanes. Learn more about ...

The number of people suffering from osteoarthritis is expected to top 1 billion by 2050. The biggest risk factor for the ...

Fabrice Gritti, consultant scientist at Waters Corporation, spoke to LCGC International about the history of slalom ...

Nutcracker Therapeutics, Inc., a contract, research, development and manufacturing organization (CRDMO) with a next ?generation RNA precision manufacturing platform, today announced its participation ...

Nutcracker Therapeutics will highlight its end-to-end microfluidic platform enabling rapid manufacturing of PCTs at leading ...

Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...

As the world marks World Immunization Week, attention turns once again to the lifesaving power of vaccines.Amid headlines about rising cases of measles, falling vaccination rates and growing vaccine ...